Arcus Biosciences
$15.48
24H
Market Cap
Volume
Supply
Price Chart
About Arcus Biosciences - RCUS
Arcus Biosciences, Inc. is a biopharmaceutical company focused on the development and commercialization of cancer immunotherapies. They work on discovering and developing therapies meant to enhance the body's immune response against various types of cancer.
What are Arcus Biosciences's core values and mission statement?
Arcus Biosciences, Inc.'s core values focus on a dedication to rigorous science, collaborative teamwork, and a commitment to improving patients' lives. Their mission is to discover, develop, and commercialize cancer therapies that leverage the body’s immune system to bring long-lasting benefit to patients.
Who founded Arcus Biosciences and when?
Arcus Biosciences, Inc. was founded by Terry Rosen and Juan Jaen in 2015.
Who leads Arcus Biosciences?
Arcus Biosciences, Inc. is led by Terry Rosen, Ph.D., who is the CEO and co-founder of the company.
Where is Arcus Biosciences located, and what is its base country?
Arcus Biosciences, Inc. is headquartered in Hayward, California, and its base country is the United States.
On which exchanges is Arcus Biosciences traded?
Arcus Biosciences, Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "RCUS."
Historical data
Arcus Biosciences (RCUS) Price Live Data
The live price of Arcus Biosciences (RCUS) is $15.48, with a trading volume of 288,297 in the last 24 hours. Wrapstocks updates the RCUS price in real-time. Arcus Biosciences is down -0.13% in the last 24 hours. The company has a live market cap of $1,406,587,008.00 and a supply of 90,864,794 RCUS stocks.
Arcus Biosciences (RCUS) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 12 hours and 15 minutes.
